methyl (2R,3R)-3-hydroxy-2-(2-methylpropyl)pentanoate | 212609-77-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羟基酸及其衍生物
• 英文名称: methyl (2R,3R)-3-hydroxy-2-(2-methylpropyl)pentanoate
• CAS: 212609-77-3
• 化学式: C₁₀H₂₀O₃
• 分子量: 188.267
• InChiKey: UABACFHLVBQPCO-RKDXNWHRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl (2R,3R)-3-hydroxy-2-(2-methylpropyl)pentanoate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 (2R,3R)-3-hydroxy-2-(2-methylpropyl)pentanoic acid
  参考文献：
  名称：

  N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution

  摘要：

  N-Hydroxyformamide-class metalloprotease inhibitors were designed and synthesized, which have potent broad-spectrum activity versus matrix metalloproteases and TNF-x converting enzyme (TACE). Compound 13c possesses good oral and intravenous pharmacokinetics in the rat and dog. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00377-8
• 作为产物：
  描述：

  (-)-(R)-3-羟基戊酸甲酯 在 palladium on activated charcoal 氢气 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 为溶剂， -78.0 ℃ 、344.74 kPa 条件下， 生成 methyl (2R,3R)-3-hydroxy-2-(2-methylpropyl)pentanoate
  参考文献：
  名称：

  N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution

  摘要：

  N-Hydroxyformamide-class metalloprotease inhibitors were designed and synthesized, which have potent broad-spectrum activity versus matrix metalloproteases and TNF-x converting enzyme (TACE). Compound 13c possesses good oral and intravenous pharmacokinetics in the rat and dog. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(01)00377-8

文献信息

• N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution
  作者：David L. Musso、Marc W. Andersen、Robert C. Andrews、Richard Austin、Elizabeth J. Beaudet、J.David Becherer、Dulce G. Bubacz、D.Mark Bickett、Joseph H. Chan、James G. Conway、David J. Cowan、Michael D. Gaul、Kimberly C. Glennon、Kevin M. Hedeen、Millard H. Lambert、M.Anthony Leesnitzer、Darryl L. McDougald、Justin L. Mitchell、Marcia L. Moss、Michael H. Rabinowitz、Michele C. Rizzolio、Lee T. Schaller、Jennifer B. Stanford、Timothy K. Tippin、Janet R. Warner、L.Graham Whitesell、Robert W. Wiethe

  DOI：10.1016/s0960-894x(01)00377-8

  日期：2001.8

  N-Hydroxyformamide-class metalloprotease inhibitors were designed and synthesized, which have potent broad-spectrum activity versus matrix metalloproteases and TNF-x converting enzyme (TACE). Compound 13c possesses good oral and intravenous pharmacokinetics in the rat and dog. (C) 2001 Elsevier Science Ltd. All rights reserved.